Want to see TSE:DOCT full AI Analyst Report?
Beyond Medical Technologies Inc (DOCT) AI Stock Analysis
Beyond Medical Technologies Inc
(CNQX:DOCT)
The score is primarily weighed down by very weak financial performance—minimal/unstable revenue, large ongoing losses, negative operating/free cash flow, and negative equity with high leverage. Technicals provide some offset with strong recent momentum (price above key moving averages and positive MACD), but overbought readings (high RSI/Stoch) add near-term risk. Valuation remains unattractive because the negative P/E reflects unprofitability and there is no dividend support.
Beyond Medical Technologies Inc (DOCT) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 5.57M
- Dividend Yield
- ―
- Average Volume (3M)
- 3,898
- Price to Earnings (P/E)
- -0.7
- Beta (1Y)
- 1.28
- Revenue Growth
- ―
- EPS Growth
- -156.09%
- Country
- Canada
- Employees
- 3
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Industrial - Pollution & Treatment Controls
Beyond Medical Technologies Inc Business Overview & Revenue Model
Company Description
Republic Technologies Inc. provides Ethereum-based technology services. The company develops Validity Network, an attestation platform that provides cryptographically secure and tamper-resistant assurances of data integrity by anchoring data commitme...
Beyond Medical Technologies Inc Financial Statement Overview
Summary
Financials are highly distressed: revenue is extremely small and deteriorated sharply in TTM (including turning negative), losses are large and persistent, operating/free cash flow are negative with ongoing burn, and the balance sheet shows very high leverage with negative equity in TTM—raising solvency, refinancing, and dilution risk.
Income Statement
6Very NegativeBalance Sheet
8Very NegativeCash Flow
7Very Negative| Breakdown | TTM | Jun 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.48K | 11.48K | 0 | 0 | 0 | 943.42K |
| Gross Profit | 11.48K | 11.48K | 0 | 0 | 0 | -250.00K |
| EBITDA | -1.49M | -2.09M | 0 | -37.96K | -772.91K | -1.26M |
| Net Income | -2.04M | -2.68M | -285 | -596.00K | -1.40M | -2.91M |
Balance Sheet | ||||||
| Total Assets | 15.85M | 15.85M | 13.80K | 95.64K | 608.18K | 1.95M |
| Cash, Cash Equivalents and Short-Term Investments | 2.76M | 2.76M | 13.22K | 64.14K | 536.75K | 1.43M |
| Total Debt | 11.86M | 11.86M | 60.00K | 30.00K | 0 | 85.09K |
| Total Liabilities | 15.71M | 15.71M | 634.46K | 430.35K | 346.94K | 413.28K |
| Stockholders Equity | 133.53K | 133.53K | -620.66K | -334.72K | 261.25K | 1.54M |
Cash Flow | ||||||
| Free Cash Flow | -1.43M | -1.70M | -109.77K | -527.04K | -894.01K | -1.47M |
| Operating Cash Flow | -1.43M | -1.70M | -109.77K | -527.04K | -894.01K | -1.40M |
| Investing Cash Flow | -2.02M | -677.07K | 0 | 0 | 0 | -467.99K |
| Financing Cash Flow | 6.20M | 5.13M | 30.00K | 30.00K | 0 | 2.67M |
Beyond Medical Technologies Inc Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DOCT, the sentiment is Neutral. The current price of 0.17 is below the 20-day moving average (MA) of 0.18, below the 50-day MA of 0.17, and above the 200-day MA of 0.17, indicating a neutral trend. The MACD of -0.00 indicates Positive momentum. The RSI at 37.25 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:DOCT.
Beyond Medical Technologies Inc Peers Comparison
Overall Rating
TSE:APL45Neutral- TSE:DOCT44Neutral
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:DOCT | Beyond Medical Technologies Inc | 0.17 | -0.27 | -60.92% | |
| TSE:APL | Appulse Corp | 0.23 | 0.01 | 2.22% |
Beyond Medical Technologies Inc Corporate Events
Republic Technologies Shares Resume Trading After Cease Trade Order Revoked
PositiveRepublic Technologies Inc. has regained regulatory compliance after the British Columbia Securities Commission revoked its failure-to-file cease trade order effective August 4, 2026. The company’s common shares resumed trading on the Canadian S...
Republic Technologies Refiles Amended Interim Financials After BCSC Review
NeutralRepublic Technologies Inc. has amended and refiled its interim financial statements and management’s discussion and analysis for the three- and nine-month periods ended September 30, 2025 and 2024 following a review by the British Columbia Secu...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 06, 2026